A: The Commission's independence rules apply to audits of financial statements required by SEC rules, except for those required by Rule 3-05 and 3-14 of Regulation S-X and Item 310(c) and (e) of Regulation S-B.
1 The Centers for Disease Control and Prevention (CDC) recommends 2 doses of quadrivalent meningococcal conjugate vaccine for adolescents 11 through 18 years of age.  The first dose should be given at 11 or 12 years of age, followed by a booster dose at age 16.
Although MCV4 is the preferred vaccine for most people, if it is not available when it's time for the vaccination, MPSV4 can be used. Routine immunization with the meningococcal vaccine MCV4 is recommended for children aged 11 or 12, with a booster to be given between ages 16 and 18. Preteens who are 11 and 12 usually have the shot at their 11- or 12-year-old checkup.